admin, Author at Rabt Global

Navigating the Regulatory Maze:
Generative AI’s Impact on Life Sciences Transformation

In the realm of life sciences, artificial intelligence (AI) has long been a cornerstone, driving advancements in drug discovery, clinical trial optimization, and personalized patient care. However, a new player has entered the scene, ushering in a wave of innovation that

Promise Pilot Pathway Update: A New
Chapter in Access to Life-Saving Medications

In the ever-evolving landscape of global healthcare, a promising update has emerged, marking a significant step forward in the journey toward faster access to life-saving medications. The Therapeutic Goods Administration (TGA) in Australia has recently shared exciting news about the progress

2023:A Year of Regulatory Revolution in
Life Sciences

2023: A Year of Regulatory Revolution in Life Sciences 2023 was a whirlwind year for the life sciences industry, with regulatory changes and advancements coming at a breakneck pace. Here's a quick throwback on some of the key highlights: Regulatory Landscape:

Comprehensive Guidelines for the
Development of Drugs and Biological
Products to Combat COVID-19: Industry Insights

Comprehensive Guidelines for the Development of Drugs and Biological Products to Combat COVID-19: Industry Insights The FDA's recommendations concentrate on phases 2 and 3 trials, encompassing critical elements such as trial population, design, efficacy endpoints, safety considerations, and statistical aspects. In

UK Responsible Person Service
A Must-Have for Foreign Medical Device
Manufacturers

UK Responsible Person Service A Must-Have for Foreign Medical Device Manufacturers The UK Responsible Person (UKRP) is a critical partner for foreign medical device manufacturers who wish to market their products in the United Kingdom. After Brexit, all foreign manufacturers must

FDA Takes Steps to Improve Efficiency
of PMR/PMC Submissions

FDA Takes Steps to Improve Efficiency of PMR/PMC Submissions The Food and Drug Administration (FDA) has released draft guidance for industry on the use of new Forms FDA 3988 and FDA 3989 to submit information on post-marketing requirements (PMRs) and post-marketing

Predetermined Change Control Plans (PCCPs)
for Machine Learning Medical Devices (MLMDs)
Guiding Principles

Predetermined Change Control Plans (PCCPs) for Machine Learning Medical Devices (MLMDs) Guiding Principles Artificial intelligence (AI) and machine learning (ML) are rapidly transforming healthcare. MLMDs are medical devices that use AI and ML to enhance their performance and capabilities. However, the

Navigating the Shifting Tides of
Regulatory Compliance in Life Sciences

Navigating the Shifting Tides of Regulatory Compliance in Life Sciences In the dynamic world of life sciences, pharmaceuticals, and medical devices, staying updated on regulatory trends is essential for success. Let's explore the evolving landscape and how end-to-end regulatory services are

Implementing Good Manufacturing Practice
(GMP) Evidence for Drug Substance (DS)
Manufacturers in Singapore

Implementing Good Manufacturing Practice (GMP) Evidence for Drug Substance (DS) Manufacturers in Singapore In its unwavering commitment to ensuring the highest standards of quality for therapeutic products available in Singapore, the Health Sciences Authority (HSA) is embarking on a significant regulatory

Navigating the FDA’s New ANDA
Filing Review Policies: What You Need to Know

Navigating the FDA's New ANDA Filing Review Policies: What You Need to Know The US Food and Drug Administration (FDA) has recently implemented significant updates to its policies regarding the review process for Abbreviated New Drug Applications (ANDAs). This move marks

FDA’s Electronic Submission Template for
Medical Device 510(k) Submissions

FDA's Electronic Submission Template for Medical Device 510(k) Submissions The Food and Drug Administration (FDA) is taking a significant step forward in streamlining the process for submitting premarket notification (510(k)) submissions for medical devices. This guidance document is designed to introduce

Navigating Health-Based Exposure Limits
in Pharmaceuticals A Path to Safety
and Compliance

Navigating Health-Based Exposure Limits in Pharmaceuticals A Path to Safety and Compliance In the pharmaceutical industry, health-based exposure limits are crucial for safeguarding against potential health risks. These limits have traditionally been used to protect workers in pharmaceutical manufacturing and are

PMA Submissions Choosing the
Right Path for Medical Device Approval

PMA Submissions Choosing the Right Path for Medical Device Approval Selecting the appropriate Premarket Approval (PMA) method can be a make-or-break decision for your growing medical device startup or scale-up. The wrong choice can waste valuable time, energy, and money, potentially

Navigating the SaMD Revolution Innovations in Healthcare Technology

Navigating the SaMD Revolution Innovations in Healthcare Technology The field of Software as a Medical Device (SaMD) is currently undergoing rapid expansion, providing groundbreaking solutions that improve patient care while curbing healthcare costs. SaMD, as defined by the International Medical Device

Navigating Regulatory Change in the
Life Sciences Industry: Key Changes
and Your Roadmap to Readiness

Navigating Regulatory Change in the Life Sciences Industry: Key Changes and Your Roadmap to Readiness In the rapidly evolving life sciences landscape, organizations are finding resilience to be a cornerstone of success, especially in the face of challenges like economic pressures,

1 2 3

Author: admin